 Global General Medicines Market Growth 2026-2032
The global General Medicines market size is predicted to grow from US$ 42990 million in 2025 to US$ 57230 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032. General Medic... もっと見る
図表リストList of TablesTable 1. General Medicines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. General Medicines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Over-the-Counter (OTC) Table 4. Major Players of Prescription (Rx) Table 5. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 6. Global General Medicines Sales Market Share by Type (2021-2026) Table 7. Global General Medicines Revenue by Type (2021-2026) & ($ million) Table 8. Global General Medicines Revenue Market Share by Type (2021-2026) Table 9. Global General Medicines Sale Price by Type (2021-2026) & (US$/Unit) Table 10. Global General Medicines Sale by Application (2021-2026) & (K Units) Table 11. Global General Medicines Sale Market Share by Application (2021-2026) Table 12. Global General Medicines Revenue by Application (2021-2026) & ($ million) Table 13. Global General Medicines Revenue Market Share by Application (2021-2026) Table 14. Global General Medicines Sale Price by Application (2021-2026) & (US$/Unit) Table 15. Global General Medicines Sales by Company (2021-2026) & (K Units) Table 16. Global General Medicines Sales Market Share by Company (2021-2026) Table 17. Global General Medicines Revenue by Company (2021-2026) & ($ millions) Table 18. Global General Medicines Revenue Market Share by Company (2021-2026) Table 19. Global General Medicines Sale Price by Company (2021-2026) & (US$/Unit) Table 20. Key Manufacturers General Medicines Producing Area Distribution and Sales Area Table 21. Players General Medicines Products Offered Table 22. General Medicines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global General Medicines Sales by Geographic Region (2021-2026) & (K Units) Table 26. Global General Medicines Sales Market Share Geographic Region (2021-2026) Table 27. Global General Medicines Revenue by Geographic Region (2021-2026) & ($ millions) Table 28. Global General Medicines Revenue Market Share by Geographic Region (2021-2026) Table 29. Global General Medicines Sales by Country/Region (2021-2026) & (K Units) Table 30. Global General Medicines Sales Market Share by Country/Region (2021-2026) Table 31. Global General Medicines Revenue by Country/Region (2021-2026) & ($ millions) Table 32. Global General Medicines Revenue Market Share by Country/Region (2021-2026) Table 33. Americas General Medicines Sales by Country (2021-2026) & (K Units) Table 34. Americas General Medicines Sales Market Share by Country (2021-2026) Table 35. Americas General Medicines Revenue by Country (2021-2026) & ($ millions) Table 36. Americas General Medicines Sales by Type (2021-2026) & (K Units) Table 37. Americas General Medicines Sales by Application (2021-2026) & (K Units) Table 38. APAC General Medicines Sales by Region (2021-2026) & (K Units) Table 39. APAC General Medicines Sales Market Share by Region (2021-2026) Table 40. APAC General Medicines Revenue by Region (2021-2026) & ($ millions) Table 41. APAC General Medicines Sales by Type (2021-2026) & (K Units) Table 42. APAC General Medicines Sales by Application (2021-2026) & (K Units) Table 43. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 44. Europe General Medicines Revenue by Country (2021-2026) & ($ millions) Table 45. Europe General Medicines Sales by Type (2021-2026) & (K Units) Table 46. Europe General Medicines Sales by Application (2021-2026) & (K Units) Table 47. Middle East & Africa General Medicines Sales by Country (2021-2026) & (K Units) Table 48. Middle East & Africa General Medicines Revenue Market Share by Country (2021-2026) Table 49. Middle East & Africa General Medicines Sales by Type (2021-2026) & (K Units) Table 50. Middle East & Africa General Medicines Sales by Application (2021-2026) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of General Medicines Table 52. Key Market Challenges & Risks of General Medicines Table 53. Key Industry Trends of General Medicines Table 54. General Medicines Raw Material Table 55. Key Suppliers of Raw Materials Table 56. General Medicines Distributors List Table 57. General Medicines Customer List Table 58. Global General Medicines Sales Forecast by Region (2027-2032) & (K Units) Table 59. Global General Medicines Revenue Forecast by Region (2027-2032) & ($ millions) Table 60. Americas General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 61. Americas General Medicines Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 62. APAC General Medicines Sales Forecast by Region (2027-2032) & (K Units) Table 63. APAC General Medicines Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 64. Europe General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 65. Europe General Medicines Revenue Forecast by Country (2027-2032) & ($ millions) Table 66. Middle East & Africa General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 67. Middle East & Africa General Medicines Revenue Forecast by Country (2027-2032) & ($ millions) Table 68. Global General Medicines Sales Forecast by Type (2027-2032) & (K Units) Table 69. Global General Medicines Revenue Forecast by Type (2027-2032) & ($ millions) Table 70. Global General Medicines Sales Forecast by Application (2027-2032) & (K Units) Table 71. Global General Medicines Revenue Forecast by Application (2027-2032) & ($ millions) Table 72. Eli Lilly Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 73. Eli Lilly General Medicines Product Portfolios and Specifications Table 74. Eli Lilly General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eli Lilly Main Business Table 76. Eli Lilly Latest Developments Table 77. Novo Nordisk Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 78. Novo Nordisk General Medicines Product Portfolios and Specifications Table 79. Novo Nordisk General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novo Nordisk Main Business Table 81. Novo Nordisk Latest Developments Table 82. Johnson & Johnson Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 83. Johnson & Johnson General Medicines Product Portfolios and Specifications Table 84. Johnson & Johnson General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Main Business Table 86. Johnson & Johnson Latest Developments Table 87. Merck Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 88. Merck General Medicines Product Portfolios and Specifications Table 89. Merck General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck Main Business Table 91. Merck Latest Developments Table 92. AbbVie Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 93. AbbVie General Medicines Product Portfolios and Specifications Table 94. AbbVie General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AbbVie Main Business Table 96. AbbVie Latest Developments Table 97. Roche Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 98. Roche General Medicines Product Portfolios and Specifications Table 99. Roche General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Roche Main Business Table 101. Roche Latest Developments Table 102. AstraZeneca Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 103. AstraZeneca General Medicines Product Portfolios and Specifications Table 104. AstraZeneca General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Main Business Table 106. AstraZeneca Latest Developments Table 107. Novartis Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 108. Novartis General Medicines Product Portfolios and Specifications Table 109. Novartis General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Novartis Main Business Table 111. Novartis Latest Developments Table 112. Pfizer Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 113. Pfizer General Medicines Product Portfolios and Specifications Table 114. Pfizer General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer Main Business Table 116. Pfizer Latest Developments Table 117. Amgen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 118. Amgen General Medicines Product Portfolios and Specifications Table 119. Amgen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Amgen Main Business Table 121. Amgen Latest Developments Table 122. Sanofi Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 123. Sanofi General Medicines Product Portfolios and Specifications Table 124. Sanofi General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Main Business Table 126. Sanofi Latest Developments Table 127. Bristol-Myers Squibb Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 128. Bristol-Myers Squibb General Medicines Product Portfolios and Specifications Table 129. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Bristol-Myers Squibb Main Business Table 131. Bristol-Myers Squibb Latest Developments Table 132. Gilead Sciences Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 133. Gilead Sciences General Medicines Product Portfolios and Specifications Table 134. Gilead Sciences General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Gilead Sciences Main Business Table 136. Gilead Sciences Latest Developments Table 137. Vertex Pharmaceuticals Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 138. Vertex Pharmaceuticals General Medicines Product Portfolios and Specifications Table 139. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Vertex Pharmaceuticals Main Business Table 141. Vertex Pharmaceuticals Latest Developments Table 142. CVS Health Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 143. CVS Health General Medicines Product Portfolios and Specifications Table 144. CVS Health General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. CVS Health Main Business Table 146. CVS Health Latest Developments Table 147. Regeneron Pharmaceuticals Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 148. Regeneron Pharmaceuticals General Medicines Product Portfolios and Specifications Table 149. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Regeneron Pharmaceuticals Main Business Table 151. Regeneron Pharmaceuticals Latest Developments Table 152. Zoetis Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 153. Zoetis General Medicines Product Portfolios and Specifications Table 154. Zoetis General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Zoetis Main Business Table 156. Zoetis Latest Developments Table 157. GlaxoSmithKline Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 158. GlaxoSmithKline General Medicines Product Portfolios and Specifications Table 159. GlaxoSmithKline General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. GlaxoSmithKline Main Business Table 161. GlaxoSmithKline Latest Developments Table 162. Daiichi Sankyō Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 163. Daiichi Sankyō General Medicines Product Portfolios and Specifications Table 164. Daiichi Sankyō General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Daiichi Sankyō Main Business Table 166. Daiichi Sankyō Latest Developments Table 167. Chugai Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 168. Chugai Pharmaceutical General Medicines Product Portfolios and Specifications Table 169. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Chugai Pharmaceutical Main Business Table 171. Chugai Pharmaceutical Latest Developments Table 172. Takeda Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 173. Takeda Pharmaceutical General Medicines Product Portfolios and Specifications Table 174. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Takeda Pharmaceutical Main Business Table 176. Takeda Pharmaceutical Latest Developments Table 177. Bayer Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 178. Bayer General Medicines Product Portfolios and Specifications Table 179. Bayer General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Bayer Main Business Table 181. Bayer Latest Developments Table 182. Seagen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 183. Seagen General Medicines Product Portfolios and Specifications Table 184. Seagen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Seagen Main Business Table 186. Seagen Latest Developments Table 187. Jiangsu Hengrui Medicine Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 188. Jiangsu Hengrui Medicine General Medicines Product Portfolios and Specifications Table 189. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Jiangsu Hengrui Medicine Main Business Table 191. Jiangsu Hengrui Medicine Latest Developments Table 192. Biogen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 193. Biogen General Medicines Product Portfolios and Specifications Table 194. Biogen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Biogen Main Business Table 196. Biogen Latest Developments Table 197. Moderna Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 198. Moderna General Medicines Product Portfolios and Specifications Table 199. Moderna General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Moderna Main Business Table 201. Moderna Latest Developments Table 202. Lonza Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 203. Lonza General Medicines Product Portfolios and Specifications Table 204. Lonza General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. Lonza Main Business Table 206. Lonza Latest Developments Table 207. Sun Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 208. Sun Pharmaceutical General Medicines Product Portfolios and Specifications Table 209. Sun Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 210. Sun Pharmaceutical Main Business Table 211. Sun Pharmaceutical Latest Developments Table 212. Argenx Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 213. Argenx General Medicines Product Portfolios and Specifications Table 214. Argenx General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 215. Argenx Main Business Table 216. Argenx Latest Developments Table 217. Horizon Therapeutics Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 218. Horizon Therapeutics General Medicines Product Portfolios and Specifications Table 219. Horizon Therapeutics General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 220. Horizon Therapeutics Main Business Table 221. Horizon Therapeutics Latest Developments List of Figures Figure 1. Picture of General Medicines Figure 2. General Medicines Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global General Medicines Sales Growth Rate 2021-2032 (K Units) Figure 7. Global General Medicines Revenue Growth Rate 2021-2032 ($ millions) Figure 8. General Medicines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. General Medicines Sales Market Share by Country/Region (2025) Figure 10. General Medicines Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Over-the-Counter (OTC) Figure 12. Product Picture of Prescription (Rx) Figure 13. Global General Medicines Sales Market Share by Type in 2026 Figure 14. Global General Medicines Revenue Market Share by Type (2021-2026) Figure 15. General Medicines Consumed in Antibiotics Figure 16. Global General Medicines Market: Antibiotics (2021-2026) & (K Units) Figure 17. General Medicines Consumed in Analgesics Figure 18. Global General Medicines Market: Analgesics (2021-2026) & (K Units) Figure 19. General Medicines Consumed in Antipyretics Figure 20. Global General Medicines Market: Antipyretics (2021-2026) & (K Units) Figure 21. General Medicines Consumed in Antihypertensives Figure 22. Global General Medicines Market: Antihypertensives (2021-2026) & (K Units) Figure 23. General Medicines Consumed in Antidiabetic Drugs Figure 24. Global General Medicines Market: Antidiabetic Drugs (2021-2026) & (K Units) Figure 25. General Medicines Consumed in Others Figure 26. Global General Medicines Market: Others (2021-2026) & (K Units) Figure 27. Global General Medicines Sale Market Share by Application (2025) Figure 28. Global General Medicines Revenue Market Share by Application in 2026 Figure 29. General Medicines Sales by Company in 2026 (K Units) Figure 30. Global General Medicines Sales Market Share by Company in 2026 Figure 31. General Medicines Revenue by Company in 2026 ($ millions) Figure 32. Global General Medicines Revenue Market Share by Company in 2026 Figure 33. Global General Medicines Sales Market Share by Geographic Region (2021-2026) Figure 34. Global General Medicines Revenue Market Share by Geographic Region in 2026 Figure 35. Americas General Medicines Sales 2021-2026 (K Units) Figure 36. Americas General Medicines Revenue 2021-2026 ($ millions) Figure 37. APAC General Medicines Sales 2021-2026 (K Units) Figure 38. APAC General Medicines Revenue 2021-2026 ($ millions) Figure 39. Europe General Medicines Sales 2021-2026 (K Units) Figure 40. Europe General Medicines Revenue 2021-2026 ($ millions) Figure 41. Middle East & Africa General Medicines Sales 2021-2026 (K Units) Figure 42. Middle East & Africa General Medicines Revenue 2021-2026 ($ millions) Figure 43. Americas General Medicines Sales Market Share by Country in 2026 Figure 44. Americas General Medicines Revenue Market Share by Country (2021-2026) Figure 45. Americas General Medicines Sales Market Share by Type (2021-2026) Figure 46. Americas General Medicines Sales Market Share by Application (2021-2026) Figure 47. United States General Medicines Revenue Growth 2021-2026 ($ millions) Figure 48. Canada General Medicines Revenue Growth 2021-2026 ($ millions) Figure 49. Mexico General Medicines Revenue Growth 2021-2026 ($ millions) Figure 50. Brazil General Medicines Revenue Growth 2021-2026 ($ millions) Figure 51. APAC General Medicines Sales Market Share by Region in 2026 Figure 52. APAC General Medicines Revenue Market Share by Region (2021-2026) Figure 53. APAC General Medicines Sales Market Share by Type (2021-2026) Figure 54. APAC General Medicines Sales Market Share by Application (2021-2026) Figure 55. China General Medicines Revenue Growth 2021-2026 ($ millions) Figure 56. Japan General Medicines Revenue Growth 2021-2026 ($ millions) Figure 57. South Korea General Medicines Revenue Growth 2021-2026 ($ millions) Figure 58. Southeast Asia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 59. India General Medicines Revenue Growth 2021-2026 ($ millions) Figure 60. Australia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 61. China Taiwan General Medicines Revenue Growth 2021-2026 ($ millions) Figure 62. Europe General Medicines Sales Market Share by Country in 2026 Figure 63. Europe General Medicines Revenue Market Share by Country (2021-2026) Figure 64. Europe General Medicines Sales Market Share by Type (2021-2026) Figure 65. Europe General Medicines Sales Market Share by Application (2021-2026) Figure 66. Germany General Medicines Revenue Growth 2021-2026 ($ millions) Figure 67. France General Medicines Revenue Growth 2021-2026 ($ millions) Figure 68. UK General Medicines Revenue Growth 2021-2026 ($ millions) Figure 69. Italy General Medicines Revenue Growth 2021-2026 ($ millions) Figure 70. Russia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 71. Middle East & Africa General Medicines Sales Market Share by Country (2021-2026) Figure 72. Middle East & Africa General Medicines Sales Market Share by Type (2021-2026) Figure 73. Middle East & Africa General Medicines Sales Market Share by Application (2021-2026) Figure 74. Egypt General Medicines Revenue Growth 2021-2026 ($ millions) Figure 75. South Africa General Medicines Revenue Growth 2021-2026 ($ millions) Figure 76. Israel General Medicines Revenue Growth 2021-2026 ($ millions) Figure 77. Turkey General Medicines Revenue Growth 2021-2026 ($ millions) Figure 78. GCC Countries General Medicines Revenue Growth 2021-2026 ($ millions) Figure 79. Manufacturing Cost Structure Analysis of General Medicines in 2026 Figure 80. Manufacturing Process Analysis of General Medicines Figure 81. Industry Chain Structure of General Medicines Figure 82. Channels of Distribution Figure 83. Global General Medicines Sales Market Forecast by Region (2027-2032) Figure 84. Global General Medicines Revenue Market Share Forecast by Region (2027-2032) Figure 85. Global General Medicines Sales Market Share Forecast by Type (2027-2032) Figure 86. Global General Medicines Revenue Market Share Forecast by Type (2027-2032) Figure 87. Global General Medicines Sales Market Share Forecast by Application (2027-2032) Figure 88. Global General Medicines Revenue Market Share Forecast by Application (2027-2032)
SummaryThe global General Medicines market size is predicted to grow from US$ 42990 million in 2025 to US$ 57230 million in 2032; it is expected to grow at a CAGR of 4.3% from 2026 to 2032.General Medicines refer to a broad category of pharmaceutical drugs and treatments used to prevent, diagnose, manage, or treat a wide range of common medical conditions. These medicines are typically not specialized for a single type of disease or organ system but are used across multiple medical fields. They include antibiotics, analgesics, antipyretics, antihypertensives, antidiabetics, and other commonly prescribed medications for general healthcare and chronic or acute conditions. General medicines are foundational to routine medical care and are utilized by various hospital departments and outpatient settings. Global key General Medicines players cover Eli Lilly, Novo Nordisk, Johnson & Johnson, Merck, AbbVie, etc. Report Scope LP Information, Inc. (LPI) ' newest research report, the “General Medicines Industry Forecast” looks at past sales and reviews total world General Medicines sales in 2025, providing a comprehensive analysis by region and market sector of projected General Medicines sales for 2026 through 2032. With General Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Medicines industry. This Insight Report provides a comprehensive analysis of the global General Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on General Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global General Medicines market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Medicines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Medicines. This report presents a comprehensive overview, market shares, and growth opportunities of General Medicines market by product type, application, key manufacturers and key regions and countries. Market Segmentation Segmentation by Type: Over-the-Counter (OTC) Prescription (Rx) Segmentation by Application: Antibiotics Analgesics Antipyretics Antihypertensives Antidiabetic Drugs Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Eli Lilly Novo Nordisk Johnson & Johnson Merck AbbVie Roche AstraZeneca Novartis Pfizer Amgen Sanofi Bristol-Myers Squibb Gilead Sciences Vertex Pharmaceuticals CVS Health Regeneron Pharmaceuticals Zoetis GlaxoSmithKline Daiichi Sankyō Chugai Pharmaceutical Takeda Pharmaceutical Bayer Seagen Jiangsu Hengrui Medicine Biogen Moderna Lonza Sun Pharmaceutical Argenx Horizon Therapeutics Key Questions Addressed in this Report What is the 10-year outlook for the global General Medicines market? What factors are driving General Medicines market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do General Medicines market opportunities vary by end market size? How does General Medicines break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global General Medicines Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for General Medicines by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for General Medicines by Country/Region, 2021, 2025 & 2032 2.2 General Medicines Segment by Type 2.2.1 Over-the-Counter (OTC) 2.2.2 Prescription (Rx) 2.2.3 General Medicines Sales by Type 2.2.3.1 Global General Medicines Sales Market Share by Type (2021-2026) 2.2.3.2 Global General Medicines Revenue and Market Share by Type (2021-2026) 2.2.3.3 Global General Medicines Sale Price by Type (2021-2026) 2.3 General Medicines Segment by Application 2.3.1 Antibiotics 2.3.2 Analgesics 2.3.3 Antipyretics 2.3.4 Antihypertensives 2.3.5 Antidiabetic Drugs 2.3.6 Others 2.3.7 General Medicines Sales by Application 2.3.7.1 Global General Medicines Sale Market Share by Application (2021-2026) 2.3.7.2 Global General Medicines Revenue and Market Share by Application (2021-2026) 2.3.7.3 Global General Medicines Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global General Medicines Breakdown Data by Company 3.1.1 Global General Medicines Annual Sales by Company (2021-2026) 3.1.2 Global General Medicines Sales Market Share by Company (2021-2026) 3.2 Global General Medicines Annual Revenue by Company (2021-2026) 3.2.1 Global General Medicines Revenue by Company (2021-2026) 3.2.2 Global General Medicines Revenue Market Share by Company (2021-2026) 3.3 Global General Medicines Sale Price by Company 3.4 Key Manufacturers General Medicines Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers General Medicines Product Location Distribution 3.4.2 Players General Medicines Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for General Medicines by Geographic Region 4.1 World Historic General Medicines Market Size by Geographic Region (2021-2026) 4.1.1 Global General Medicines Annual Sales by Geographic Region (2021-2026) 4.1.2 Global General Medicines Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic General Medicines Market Size by Country/Region (2021-2026) 4.2.1 Global General Medicines Annual Sales by Country/Region (2021-2026) 4.2.2 Global General Medicines Annual Revenue by Country/Region (2021-2026) 4.3 Americas General Medicines Sales Growth 4.4 APAC General Medicines Sales Growth 4.5 Europe General Medicines Sales Growth 4.6 Middle East & Africa General Medicines Sales Growth 5 Americas 5.1 Americas General Medicines Sales by Country 5.1.1 Americas General Medicines Sales by Country (2021-2026) 5.1.2 Americas General Medicines Revenue by Country (2021-2026) 5.2 Americas General Medicines Sales by Type (2021-2026) 5.3 Americas General Medicines Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC General Medicines Sales by Region 6.1.1 APAC General Medicines Sales by Region (2021-2026) 6.1.2 APAC General Medicines Revenue by Region (2021-2026) 6.2 APAC General Medicines Sales by Type (2021-2026) 6.3 APAC General Medicines Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe General Medicines by Country 7.1.1 Europe General Medicines Sales by Country (2021-2026) 7.1.2 Europe General Medicines Revenue by Country (2021-2026) 7.2 Europe General Medicines Sales by Type (2021-2026) 7.3 Europe General Medicines Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa General Medicines by Country 8.1.1 Middle East & Africa General Medicines Sales by Country (2021-2026) 8.1.2 Middle East & Africa General Medicines Revenue by Country (2021-2026) 8.2 Middle East & Africa General Medicines Sales by Type (2021-2026) 8.3 Middle East & Africa General Medicines Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of General Medicines 10.3 Manufacturing Process Analysis of General Medicines 10.4 Industry Chain Structure of General Medicines 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 General Medicines Distributors 11.3 General Medicines Customer 12 World Forecast Review for General Medicines by Geographic Region 12.1 Global General Medicines Market Size Forecast by Region 12.1.1 Global General Medicines Forecast by Region (2027-2032) 12.1.2 Global General Medicines Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global General Medicines Forecast by Type (2027-2032) 12.7 Global General Medicines Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 Eli Lilly 13.1.1 Eli Lilly Company Information 13.1.2 Eli Lilly General Medicines Product Portfolios and Specifications 13.1.3 Eli Lilly General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 Eli Lilly Main Business Overview 13.1.5 Eli Lilly Latest Developments 13.2 Novo Nordisk 13.2.1 Novo Nordisk Company Information 13.2.2 Novo Nordisk General Medicines Product Portfolios and Specifications 13.2.3 Novo Nordisk General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Novo Nordisk Main Business Overview 13.2.5 Novo Nordisk Latest Developments 13.3 Johnson & Johnson 13.3.1 Johnson & Johnson Company Information 13.3.2 Johnson & Johnson General Medicines Product Portfolios and Specifications 13.3.3 Johnson & Johnson General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Johnson & Johnson Main Business Overview 13.3.5 Johnson & Johnson Latest Developments 13.4 Merck 13.4.1 Merck Company Information 13.4.2 Merck General Medicines Product Portfolios and Specifications 13.4.3 Merck General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Merck Main Business Overview 13.4.5 Merck Latest Developments 13.5 AbbVie 13.5.1 AbbVie Company Information 13.5.2 AbbVie General Medicines Product Portfolios and Specifications 13.5.3 AbbVie General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 AbbVie Main Business Overview 13.5.5 AbbVie Latest Developments 13.6 Roche 13.6.1 Roche Company Information 13.6.2 Roche General Medicines Product Portfolios and Specifications 13.6.3 Roche General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Roche Main Business Overview 13.6.5 Roche Latest Developments 13.7 AstraZeneca 13.7.1 AstraZeneca Company Information 13.7.2 AstraZeneca General Medicines Product Portfolios and Specifications 13.7.3 AstraZeneca General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 AstraZeneca Main Business Overview 13.7.5 AstraZeneca Latest Developments 13.8 Novartis 13.8.1 Novartis Company Information 13.8.2 Novartis General Medicines Product Portfolios and Specifications 13.8.3 Novartis General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Novartis Main Business Overview 13.8.5 Novartis Latest Developments 13.9 Pfizer 13.9.1 Pfizer Company Information 13.9.2 Pfizer General Medicines Product Portfolios and Specifications 13.9.3 Pfizer General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 Pfizer Main Business Overview 13.9.5 Pfizer Latest Developments 13.10 Amgen 13.10.1 Amgen Company Information 13.10.2 Amgen General Medicines Product Portfolios and Specifications 13.10.3 Amgen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Amgen Main Business Overview 13.10.5 Amgen Latest Developments 13.11 Sanofi 13.11.1 Sanofi Company Information 13.11.2 Sanofi General Medicines Product Portfolios and Specifications 13.11.3 Sanofi General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 Sanofi Main Business Overview 13.11.5 Sanofi Latest Developments 13.12 Bristol-Myers Squibb 13.12.1 Bristol-Myers Squibb Company Information 13.12.2 Bristol-Myers Squibb General Medicines Product Portfolios and Specifications 13.12.3 Bristol-Myers Squibb General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 Bristol-Myers Squibb Main Business Overview 13.12.5 Bristol-Myers Squibb Latest Developments 13.13 Gilead Sciences 13.13.1 Gilead Sciences Company Information 13.13.2 Gilead Sciences General Medicines Product Portfolios and Specifications 13.13.3 Gilead Sciences General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Gilead Sciences Main Business Overview 13.13.5 Gilead Sciences Latest Developments 13.14 Vertex Pharmaceuticals 13.14.1 Vertex Pharmaceuticals Company Information 13.14.2 Vertex Pharmaceuticals General Medicines Product Portfolios and Specifications 13.14.3 Vertex Pharmaceuticals General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Vertex Pharmaceuticals Main Business Overview 13.14.5 Vertex Pharmaceuticals Latest Developments 13.15 CVS Health 13.15.1 CVS Health Company Information 13.15.2 CVS Health General Medicines Product Portfolios and Specifications 13.15.3 CVS Health General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 CVS Health Main Business Overview 13.15.5 CVS Health Latest Developments 13.16 Regeneron Pharmaceuticals 13.16.1 Regeneron Pharmaceuticals Company Information 13.16.2 Regeneron Pharmaceuticals General Medicines Product Portfolios and Specifications 13.16.3 Regeneron Pharmaceuticals General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 Regeneron Pharmaceuticals Main Business Overview 13.16.5 Regeneron Pharmaceuticals Latest Developments 13.17 Zoetis 13.17.1 Zoetis Company Information 13.17.2 Zoetis General Medicines Product Portfolios and Specifications 13.17.3 Zoetis General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 Zoetis Main Business Overview 13.17.5 Zoetis Latest Developments 13.18 GlaxoSmithKline 13.18.1 GlaxoSmithKline Company Information 13.18.2 GlaxoSmithKline General Medicines Product Portfolios and Specifications 13.18.3 GlaxoSmithKline General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 GlaxoSmithKline Main Business Overview 13.18.5 GlaxoSmithKline Latest Developments 13.19 Daiichi Sankyō 13.19.1 Daiichi Sankyō Company Information 13.19.2 Daiichi Sankyō General Medicines Product Portfolios and Specifications 13.19.3 Daiichi Sankyō General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 Daiichi Sankyō Main Business Overview 13.19.5 Daiichi Sankyō Latest Developments 13.20 Chugai Pharmaceutical 13.20.1 Chugai Pharmaceutical Company Information 13.20.2 Chugai Pharmaceutical General Medicines Product Portfolios and Specifications 13.20.3 Chugai Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Chugai Pharmaceutical Main Business Overview 13.20.5 Chugai Pharmaceutical Latest Developments 13.21 Takeda Pharmaceutical 13.21.1 Takeda Pharmaceutical Company Information 13.21.2 Takeda Pharmaceutical General Medicines Product Portfolios and Specifications 13.21.3 Takeda Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 Takeda Pharmaceutical Main Business Overview 13.21.5 Takeda Pharmaceutical Latest Developments 13.22 Bayer 13.22.1 Bayer Company Information 13.22.2 Bayer General Medicines Product Portfolios and Specifications 13.22.3 Bayer General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 Bayer Main Business Overview 13.22.5 Bayer Latest Developments 13.23 Seagen 13.23.1 Seagen Company Information 13.23.2 Seagen General Medicines Product Portfolios and Specifications 13.23.3 Seagen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.23.4 Seagen Main Business Overview 13.23.5 Seagen Latest Developments 13.24 Jiangsu Hengrui Medicine 13.24.1 Jiangsu Hengrui Medicine Company Information 13.24.2 Jiangsu Hengrui Medicine General Medicines Product Portfolios and Specifications 13.24.3 Jiangsu Hengrui Medicine General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.24.4 Jiangsu Hengrui Medicine Main Business Overview 13.24.5 Jiangsu Hengrui Medicine Latest Developments 13.25 Biogen 13.25.1 Biogen Company Information 13.25.2 Biogen General Medicines Product Portfolios and Specifications 13.25.3 Biogen General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.25.4 Biogen Main Business Overview 13.25.5 Biogen Latest Developments 13.26 Moderna 13.26.1 Moderna Company Information 13.26.2 Moderna General Medicines Product Portfolios and Specifications 13.26.3 Moderna General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.26.4 Moderna Main Business Overview 13.26.5 Moderna Latest Developments 13.27 Lonza 13.27.1 Lonza Company Information 13.27.2 Lonza General Medicines Product Portfolios and Specifications 13.27.3 Lonza General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.27.4 Lonza Main Business Overview 13.27.5 Lonza Latest Developments 13.28 Sun Pharmaceutical 13.28.1 Sun Pharmaceutical Company Information 13.28.2 Sun Pharmaceutical General Medicines Product Portfolios and Specifications 13.28.3 Sun Pharmaceutical General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.28.4 Sun Pharmaceutical Main Business Overview 13.28.5 Sun Pharmaceutical Latest Developments 13.29 Argenx 13.29.1 Argenx Company Information 13.29.2 Argenx General Medicines Product Portfolios and Specifications 13.29.3 Argenx General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.29.4 Argenx Main Business Overview 13.29.5 Argenx Latest Developments 13.30 Horizon Therapeutics 13.30.1 Horizon Therapeutics Company Information 13.30.2 Horizon Therapeutics General Medicines Product Portfolios and Specifications 13.30.3 Horizon Therapeutics General Medicines Sales, Revenue, Price and Gross Margin (2021-2026) 13.30.4 Horizon Therapeutics Main Business Overview 13.30.5 Horizon Therapeutics Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. General Medicines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. General Medicines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Over-the-Counter (OTC) Table 4. Major Players of Prescription (Rx) Table 5. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 6. Global General Medicines Sales Market Share by Type (2021-2026) Table 7. Global General Medicines Revenue by Type (2021-2026) & ($ million) Table 8. Global General Medicines Revenue Market Share by Type (2021-2026) Table 9. Global General Medicines Sale Price by Type (2021-2026) & (US$/Unit) Table 10. Global General Medicines Sale by Application (2021-2026) & (K Units) Table 11. Global General Medicines Sale Market Share by Application (2021-2026) Table 12. Global General Medicines Revenue by Application (2021-2026) & ($ million) Table 13. Global General Medicines Revenue Market Share by Application (2021-2026) Table 14. Global General Medicines Sale Price by Application (2021-2026) & (US$/Unit) Table 15. Global General Medicines Sales by Company (2021-2026) & (K Units) Table 16. Global General Medicines Sales Market Share by Company (2021-2026) Table 17. Global General Medicines Revenue by Company (2021-2026) & ($ millions) Table 18. Global General Medicines Revenue Market Share by Company (2021-2026) Table 19. Global General Medicines Sale Price by Company (2021-2026) & (US$/Unit) Table 20. Key Manufacturers General Medicines Producing Area Distribution and Sales Area Table 21. Players General Medicines Products Offered Table 22. General Medicines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global General Medicines Sales by Geographic Region (2021-2026) & (K Units) Table 26. Global General Medicines Sales Market Share Geographic Region (2021-2026) Table 27. Global General Medicines Revenue by Geographic Region (2021-2026) & ($ millions) Table 28. Global General Medicines Revenue Market Share by Geographic Region (2021-2026) Table 29. Global General Medicines Sales by Country/Region (2021-2026) & (K Units) Table 30. Global General Medicines Sales Market Share by Country/Region (2021-2026) Table 31. Global General Medicines Revenue by Country/Region (2021-2026) & ($ millions) Table 32. Global General Medicines Revenue Market Share by Country/Region (2021-2026) Table 33. Americas General Medicines Sales by Country (2021-2026) & (K Units) Table 34. Americas General Medicines Sales Market Share by Country (2021-2026) Table 35. Americas General Medicines Revenue by Country (2021-2026) & ($ millions) Table 36. Americas General Medicines Sales by Type (2021-2026) & (K Units) Table 37. Americas General Medicines Sales by Application (2021-2026) & (K Units) Table 38. APAC General Medicines Sales by Region (2021-2026) & (K Units) Table 39. APAC General Medicines Sales Market Share by Region (2021-2026) Table 40. APAC General Medicines Revenue by Region (2021-2026) & ($ millions) Table 41. APAC General Medicines Sales by Type (2021-2026) & (K Units) Table 42. APAC General Medicines Sales by Application (2021-2026) & (K Units) Table 43. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 44. Europe General Medicines Revenue by Country (2021-2026) & ($ millions) Table 45. Europe General Medicines Sales by Type (2021-2026) & (K Units) Table 46. Europe General Medicines Sales by Application (2021-2026) & (K Units) Table 47. Middle East & Africa General Medicines Sales by Country (2021-2026) & (K Units) Table 48. Middle East & Africa General Medicines Revenue Market Share by Country (2021-2026) Table 49. Middle East & Africa General Medicines Sales by Type (2021-2026) & (K Units) Table 50. Middle East & Africa General Medicines Sales by Application (2021-2026) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of General Medicines Table 52. Key Market Challenges & Risks of General Medicines Table 53. Key Industry Trends of General Medicines Table 54. General Medicines Raw Material Table 55. Key Suppliers of Raw Materials Table 56. General Medicines Distributors List Table 57. General Medicines Customer List Table 58. Global General Medicines Sales Forecast by Region (2027-2032) & (K Units) Table 59. Global General Medicines Revenue Forecast by Region (2027-2032) & ($ millions) Table 60. Americas General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 61. Americas General Medicines Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 62. APAC General Medicines Sales Forecast by Region (2027-2032) & (K Units) Table 63. APAC General Medicines Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 64. Europe General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 65. Europe General Medicines Revenue Forecast by Country (2027-2032) & ($ millions) Table 66. Middle East & Africa General Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 67. Middle East & Africa General Medicines Revenue Forecast by Country (2027-2032) & ($ millions) Table 68. Global General Medicines Sales Forecast by Type (2027-2032) & (K Units) Table 69. Global General Medicines Revenue Forecast by Type (2027-2032) & ($ millions) Table 70. Global General Medicines Sales Forecast by Application (2027-2032) & (K Units) Table 71. Global General Medicines Revenue Forecast by Application (2027-2032) & ($ millions) Table 72. Eli Lilly Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 73. Eli Lilly General Medicines Product Portfolios and Specifications Table 74. Eli Lilly General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Eli Lilly Main Business Table 76. Eli Lilly Latest Developments Table 77. Novo Nordisk Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 78. Novo Nordisk General Medicines Product Portfolios and Specifications Table 79. Novo Nordisk General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novo Nordisk Main Business Table 81. Novo Nordisk Latest Developments Table 82. Johnson & Johnson Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 83. Johnson & Johnson General Medicines Product Portfolios and Specifications Table 84. Johnson & Johnson General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Main Business Table 86. Johnson & Johnson Latest Developments Table 87. Merck Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 88. Merck General Medicines Product Portfolios and Specifications Table 89. Merck General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck Main Business Table 91. Merck Latest Developments Table 92. AbbVie Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 93. AbbVie General Medicines Product Portfolios and Specifications Table 94. AbbVie General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AbbVie Main Business Table 96. AbbVie Latest Developments Table 97. Roche Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 98. Roche General Medicines Product Portfolios and Specifications Table 99. Roche General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Roche Main Business Table 101. Roche Latest Developments Table 102. AstraZeneca Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 103. AstraZeneca General Medicines Product Portfolios and Specifications Table 104. AstraZeneca General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Main Business Table 106. AstraZeneca Latest Developments Table 107. Novartis Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 108. Novartis General Medicines Product Portfolios and Specifications Table 109. Novartis General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Novartis Main Business Table 111. Novartis Latest Developments Table 112. Pfizer Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 113. Pfizer General Medicines Product Portfolios and Specifications Table 114. Pfizer General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer Main Business Table 116. Pfizer Latest Developments Table 117. Amgen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 118. Amgen General Medicines Product Portfolios and Specifications Table 119. Amgen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Amgen Main Business Table 121. Amgen Latest Developments Table 122. Sanofi Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 123. Sanofi General Medicines Product Portfolios and Specifications Table 124. Sanofi General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Main Business Table 126. Sanofi Latest Developments Table 127. Bristol-Myers Squibb Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 128. Bristol-Myers Squibb General Medicines Product Portfolios and Specifications Table 129. Bristol-Myers Squibb General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Bristol-Myers Squibb Main Business Table 131. Bristol-Myers Squibb Latest Developments Table 132. Gilead Sciences Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 133. Gilead Sciences General Medicines Product Portfolios and Specifications Table 134. Gilead Sciences General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Gilead Sciences Main Business Table 136. Gilead Sciences Latest Developments Table 137. Vertex Pharmaceuticals Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 138. Vertex Pharmaceuticals General Medicines Product Portfolios and Specifications Table 139. Vertex Pharmaceuticals General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Vertex Pharmaceuticals Main Business Table 141. Vertex Pharmaceuticals Latest Developments Table 142. CVS Health Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 143. CVS Health General Medicines Product Portfolios and Specifications Table 144. CVS Health General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. CVS Health Main Business Table 146. CVS Health Latest Developments Table 147. Regeneron Pharmaceuticals Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 148. Regeneron Pharmaceuticals General Medicines Product Portfolios and Specifications Table 149. Regeneron Pharmaceuticals General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Regeneron Pharmaceuticals Main Business Table 151. Regeneron Pharmaceuticals Latest Developments Table 152. Zoetis Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 153. Zoetis General Medicines Product Portfolios and Specifications Table 154. Zoetis General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Zoetis Main Business Table 156. Zoetis Latest Developments Table 157. GlaxoSmithKline Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 158. GlaxoSmithKline General Medicines Product Portfolios and Specifications Table 159. GlaxoSmithKline General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. GlaxoSmithKline Main Business Table 161. GlaxoSmithKline Latest Developments Table 162. Daiichi Sankyō Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 163. Daiichi Sankyō General Medicines Product Portfolios and Specifications Table 164. Daiichi Sankyō General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Daiichi Sankyō Main Business Table 166. Daiichi Sankyō Latest Developments Table 167. Chugai Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 168. Chugai Pharmaceutical General Medicines Product Portfolios and Specifications Table 169. Chugai Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Chugai Pharmaceutical Main Business Table 171. Chugai Pharmaceutical Latest Developments Table 172. Takeda Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 173. Takeda Pharmaceutical General Medicines Product Portfolios and Specifications Table 174. Takeda Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Takeda Pharmaceutical Main Business Table 176. Takeda Pharmaceutical Latest Developments Table 177. Bayer Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 178. Bayer General Medicines Product Portfolios and Specifications Table 179. Bayer General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Bayer Main Business Table 181. Bayer Latest Developments Table 182. Seagen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 183. Seagen General Medicines Product Portfolios and Specifications Table 184. Seagen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Seagen Main Business Table 186. Seagen Latest Developments Table 187. Jiangsu Hengrui Medicine Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 188. Jiangsu Hengrui Medicine General Medicines Product Portfolios and Specifications Table 189. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Jiangsu Hengrui Medicine Main Business Table 191. Jiangsu Hengrui Medicine Latest Developments Table 192. Biogen Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 193. Biogen General Medicines Product Portfolios and Specifications Table 194. Biogen General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Biogen Main Business Table 196. Biogen Latest Developments Table 197. Moderna Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 198. Moderna General Medicines Product Portfolios and Specifications Table 199. Moderna General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Moderna Main Business Table 201. Moderna Latest Developments Table 202. Lonza Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 203. Lonza General Medicines Product Portfolios and Specifications Table 204. Lonza General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 205. Lonza Main Business Table 206. Lonza Latest Developments Table 207. Sun Pharmaceutical Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 208. Sun Pharmaceutical General Medicines Product Portfolios and Specifications Table 209. Sun Pharmaceutical General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 210. Sun Pharmaceutical Main Business Table 211. Sun Pharmaceutical Latest Developments Table 212. Argenx Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 213. Argenx General Medicines Product Portfolios and Specifications Table 214. Argenx General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 215. Argenx Main Business Table 216. Argenx Latest Developments Table 217. Horizon Therapeutics Basic Information, General Medicines Manufacturing Base, Sales Area and Its Competitors Table 218. Horizon Therapeutics General Medicines Product Portfolios and Specifications Table 219. Horizon Therapeutics General Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 220. Horizon Therapeutics Main Business Table 221. Horizon Therapeutics Latest Developments List of Figures Figure 1. Picture of General Medicines Figure 2. General Medicines Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global General Medicines Sales Growth Rate 2021-2032 (K Units) Figure 7. Global General Medicines Revenue Growth Rate 2021-2032 ($ millions) Figure 8. General Medicines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. General Medicines Sales Market Share by Country/Region (2025) Figure 10. General Medicines Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Over-the-Counter (OTC) Figure 12. Product Picture of Prescription (Rx) Figure 13. Global General Medicines Sales Market Share by Type in 2026 Figure 14. Global General Medicines Revenue Market Share by Type (2021-2026) Figure 15. General Medicines Consumed in Antibiotics Figure 16. Global General Medicines Market: Antibiotics (2021-2026) & (K Units) Figure 17. General Medicines Consumed in Analgesics Figure 18. Global General Medicines Market: Analgesics (2021-2026) & (K Units) Figure 19. General Medicines Consumed in Antipyretics Figure 20. Global General Medicines Market: Antipyretics (2021-2026) & (K Units) Figure 21. General Medicines Consumed in Antihypertensives Figure 22. Global General Medicines Market: Antihypertensives (2021-2026) & (K Units) Figure 23. General Medicines Consumed in Antidiabetic Drugs Figure 24. Global General Medicines Market: Antidiabetic Drugs (2021-2026) & (K Units) Figure 25. General Medicines Consumed in Others Figure 26. Global General Medicines Market: Others (2021-2026) & (K Units) Figure 27. Global General Medicines Sale Market Share by Application (2025) Figure 28. Global General Medicines Revenue Market Share by Application in 2026 Figure 29. General Medicines Sales by Company in 2026 (K Units) Figure 30. Global General Medicines Sales Market Share by Company in 2026 Figure 31. General Medicines Revenue by Company in 2026 ($ millions) Figure 32. Global General Medicines Revenue Market Share by Company in 2026 Figure 33. Global General Medicines Sales Market Share by Geographic Region (2021-2026) Figure 34. Global General Medicines Revenue Market Share by Geographic Region in 2026 Figure 35. Americas General Medicines Sales 2021-2026 (K Units) Figure 36. Americas General Medicines Revenue 2021-2026 ($ millions) Figure 37. APAC General Medicines Sales 2021-2026 (K Units) Figure 38. APAC General Medicines Revenue 2021-2026 ($ millions) Figure 39. Europe General Medicines Sales 2021-2026 (K Units) Figure 40. Europe General Medicines Revenue 2021-2026 ($ millions) Figure 41. Middle East & Africa General Medicines Sales 2021-2026 (K Units) Figure 42. Middle East & Africa General Medicines Revenue 2021-2026 ($ millions) Figure 43. Americas General Medicines Sales Market Share by Country in 2026 Figure 44. Americas General Medicines Revenue Market Share by Country (2021-2026) Figure 45. Americas General Medicines Sales Market Share by Type (2021-2026) Figure 46. Americas General Medicines Sales Market Share by Application (2021-2026) Figure 47. United States General Medicines Revenue Growth 2021-2026 ($ millions) Figure 48. Canada General Medicines Revenue Growth 2021-2026 ($ millions) Figure 49. Mexico General Medicines Revenue Growth 2021-2026 ($ millions) Figure 50. Brazil General Medicines Revenue Growth 2021-2026 ($ millions) Figure 51. APAC General Medicines Sales Market Share by Region in 2026 Figure 52. APAC General Medicines Revenue Market Share by Region (2021-2026) Figure 53. APAC General Medicines Sales Market Share by Type (2021-2026) Figure 54. APAC General Medicines Sales Market Share by Application (2021-2026) Figure 55. China General Medicines Revenue Growth 2021-2026 ($ millions) Figure 56. Japan General Medicines Revenue Growth 2021-2026 ($ millions) Figure 57. South Korea General Medicines Revenue Growth 2021-2026 ($ millions) Figure 58. Southeast Asia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 59. India General Medicines Revenue Growth 2021-2026 ($ millions) Figure 60. Australia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 61. China Taiwan General Medicines Revenue Growth 2021-2026 ($ millions) Figure 62. Europe General Medicines Sales Market Share by Country in 2026 Figure 63. Europe General Medicines Revenue Market Share by Country (2021-2026) Figure 64. Europe General Medicines Sales Market Share by Type (2021-2026) Figure 65. Europe General Medicines Sales Market Share by Application (2021-2026) Figure 66. Germany General Medicines Revenue Growth 2021-2026 ($ millions) Figure 67. France General Medicines Revenue Growth 2021-2026 ($ millions) Figure 68. UK General Medicines Revenue Growth 2021-2026 ($ millions) Figure 69. Italy General Medicines Revenue Growth 2021-2026 ($ millions) Figure 70. Russia General Medicines Revenue Growth 2021-2026 ($ millions) Figure 71. Middle East & Africa General Medicines Sales Market Share by Country (2021-2026) Figure 72. Middle East & Africa General Medicines Sales Market Share by Type (2021-2026) Figure 73. Middle East & Africa General Medicines Sales Market Share by Application (2021-2026) Figure 74. Egypt General Medicines Revenue Growth 2021-2026 ($ millions) Figure 75. South Africa General Medicines Revenue Growth 2021-2026 ($ millions) Figure 76. Israel General Medicines Revenue Growth 2021-2026 ($ millions) Figure 77. Turkey General Medicines Revenue Growth 2021-2026 ($ millions) Figure 78. GCC Countries General Medicines Revenue Growth 2021-2026 ($ millions) Figure 79. Manufacturing Cost Structure Analysis of General Medicines in 2026 Figure 80. Manufacturing Process Analysis of General Medicines Figure 81. Industry Chain Structure of General Medicines Figure 82. Channels of Distribution Figure 83. Global General Medicines Sales Market Forecast by Region (2027-2032) Figure 84. Global General Medicines Revenue Market Share Forecast by Region (2027-2032) Figure 85. Global General Medicines Sales Market Share Forecast by Type (2027-2032) Figure 86. Global General Medicines Revenue Market Share Forecast by Type (2027-2032) Figure 87. Global General Medicines Sales Market Share Forecast by Application (2027-2032) Figure 88. Global General Medicines Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（medicines market）の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
